Download presentation
Presentation is loading. Please wait.
Published byDrusilla Morton Modified over 9 years ago
1
NEI’s Research Partnerships Around the World & Vision Loss Prevention Activities John Prakash, PhD, MBA Associate Director, International Programs National Eye Institute- National Institutes of Health Tel: (301) 496-2234; Fax:301-496-9970 Email: prakashg@mail.nih.govprakashg@mail.nih.gov Department of Health and Human Services World Sight Day 2012: From Vision Research to Vision Loss prevention October 11, 2012
2
1. Goals of the NEI International Program 2. Research Partnerships Around the World Intramural Collaborations Extramural Collaborations 3. Sample Case Studies Trachoma Corneal ulcer Brain neuroplasticity Contents
3
NIH MISSION STATEMENT An agency of the United States Department of Health and Human Services, the NIH conducts and supports medical research to uncover new knowledge that will improve the health of all Americans and the human condition throughout the world.
4
1. High-throughput technologies in genomics and nanotechnology 2. Developing diagnostics, preventative strategies and therapeutic tools through public–private partnerships 3. Reining in the costs of health care with comparative- effectiveness research and personalized medicine 4. Expanding research into diseases affecting the developing world 5. Increasing budgets and investing in training & peer review to achieve a predictable funding trajectory
5
“…to conduct and support research, training, and other programs with respect to blinding eye diseases, visual disorders, mechanisms of visual function, preservation of sight, and specific health problems and needs of the blind.” NEI Mission http://www.nei.nih.gov/
6
Office of International Programs-Global Health “Good Eye Research Anywhere is Good Eye Research Everywhere”
7
Broad Functions Coordinate and support collaborative international research programs that focus on selected eye diseases of substantial health importance to the US and other countries Maintain a knowledge base of the Institute's research programs and policies in coordination with the National Institutes of Health - Fogarty International Center (FIC) Identify relevant programs of other federal domestic agencies, bilateral research agencies, multilateral research organizations, and volunteer agencies involved in international health activities Advise the NEI Director on program relationships and opportunities for collaboration Office of International Programs-Global Health
8
Three Goals for NEI International Programs Goal I: Coordination Address the daily needs of the international business and actively participate in the NIH and the USG wide programs that may affect vision research and training Goal II: Research Collaboration Foster a sustainable international research environment, expand collaborations in the countries across the globe that are interested in the advancement of vision research, and support international partnerships providing scientific value to the NEI-NIH programs Goal III:Training Develop human capital in the US to support the future needs in the areas of vision research and training, support mentoring activities for the next generation of scientists and professionals interested in global health and vision research Goals
9
1. Goals of the NEI International Program 2. Research Partnerships Around the World Intramural Collaborations Extramural Collaborations 3. Sample Case Studies Trachoma Corneal Ulcer Brain neuroplasticity Contents
10
Summary of the Latest International Collaborative Activities at NEI-intramural >50 international collaborations, projects, affiliations, CRADAs, and other engagements on all 6 continents 40% collaborative engagements are in Asia, 35% in Europe and 25% in other countries 23 Major International Initiatives over past 2 years 6 Recent Achievements in Global Health Activities 10 International Partnerships & Collaborations 5 Current Memberships on Global Health Committees/Working Groups Currently training 66 international scientists and fellows 18 scientists trained in the past two years have gone back (to their native countries) 10
11
Major International Initiatives over Past Two years 11
12
Summary of New International Partnerships & Collaborations 1.US-NIH & UK-NIHR Collaboration with NEI, UCL and University of Bristol - UNITE 2.CRADA with Genomatix in Munich, GERMANY, to develop meta-analysis tools for “omic” data to identify novel biomarkers and to develop therapies for retinal and macular diseases 3.CRADA with Zhongshan Ophthalmic Center, Sun Yat-sen University, China 4.Indo-US Joint Working Group 5.Various ARVO – international group participation and support 6.Lowy Institution, Sydney, Australia. Participation in design & conduct of a natural history study & clinical trial 7.Retina Institute, Japan, Serving on the Scientific Advisory Board 8.Pierre and Marie Curie University, Paris, France: Collaborations with several scientists 9.Cell Cure Neurosciences, Israel. Serving as a board member for the Medical Advisory Board 10.Singapore Eye Research Institute. Serving as a member of the Scientific Advisory Panel 12
13
Trained Scientists (18), (Gone back in past 2 yrs.) International Scientists in DIR (As reported in June 2012) Current Visiting Scientists/PDFs (66) 13
14
NEI Extramural Programs Funded NEI Grants – International Programs ArgentinaPrimary Open Angle Glaucoma AustraliaNuclear Cataract CanadaRetinal Stem Cells ChinaGenetics of Age-related Macular Deg. DenmarkDiabetic Retinopathy EthiopiaTrachoma FranceRetinal Pigment Epithelial/Stem Cells GermanyAdvanced Imaging for Eye Diseases GhanaGlaucoma Genetic Risk Factors IndiaCornea Ulcers Trial Project Prakash IsraelPhototransduction ItalyOxidative Damage to TM-Glaucoma JapanMacular Degeneration SwitzerlandNanofabrication technology/T cells UK Various Eye Disorders Supports 26 grants and 36 foreign sites in 15 countries
15
1. Goals of the NEI International Program 2. Research Partnerships Around the World Intramural Collaborations Extramural Collaborations 3. Sample Case Studies Trachoma Corneal Ulcer Brain neuroplasticity Contents
16
US Public Health Service officers examining migrants at Ellis Island —slide (modified) courtesy of Prof. Hugh Taylor Civilian Populations – Crowded Slums of Industrial Revolution
17
Avoidable Blindness: Trachoma affects 11 Million People Worldwide —photos courtesy of Emily West, STAR Study Team Chlamydia trachomatis bacterial infection
18
STAR TRIAL - Eye Research Leads the Way: Single-dose Antibiotic Reduces Recurrence of In-turned Eyelashes after Surgery STAR Study - S urgery for T richiasis, A ntibiotics for R ecurrence. An NEI-funded clinical trial partnered with ORBIS International. in Archives of Ophthalmology, March 2006 —photo courtesy of Emily West, STAR Study Team
19
—slide (modified) courtesy of Prof. Hugh Taylor Biannual Treatment of Azithromycin is Effective 145 million doses to date
20
Trachoma Vaccine ? A new vaccine tested in monkeys shows promise against the disease. If successful in humans, it could be a very helpful tool within the global strategy NIAID, NIH-funded research J. Exp. Med. 2011;208(11):2217-23.
21
Treatment – Topical Corticosteroids Found To Heal Severe Bacterial Corneal Ulcers Researchers found significant vision improvement—one and a half to two lines of improvement on an eye chart—by using corticosteroid therapy on patients with severe ulcers. Steroids for Corneal Ulcers Trial (SCUT) - Arch Ophthalmol:130, Feb 2012 UCSF and the Aravind Eye Care System, in Madurai, India 500 participants with culture-positive bacterial corneal ulcer from US & India Randomized placebo-controlled trial from September 2006-February 2010 Half of the patients received 1% topical prednisolone sodium phosphate treatment and the other half received placebos. No difference in overall group, but a difference in severe ulcers subgroup NEI-supported International Research
22
PROJECT PRAKASH
23
Project Prakash-Video
24
The NEI’s New World Questions/Comments?
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.